Bharat Parenterals Ltd

NSE: BPLPHARMA · BSE: 541096 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹1,876.85
Market cap: ₹1,294 Cr
Revenue (annual): ₹345.4 Cr
Net profit (annual): ₹-8.19 Cr
P/E (TTM): -84.0×Sector 47.3×
Promoter holding: 67.20%+0.03% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 4 Promoter Buying 3 Other Announcement 3 Management Change 3 Board Meeting Date 3 Annual General Meeting 2 Price Movement Clarification 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

5 Aug 2026 17:41 IST BSE

Financial Results

Bharat Parenterals Q1 FY27 Results: Net Loss of ₹3.6 Cr, Loss Widens

Bharat Parenterals Ltd reported revenue from operations of ₹93.7 Cr (-19.2% YoY) and a net loss of ₹3.6 Cr for Q1 FY27.

Key figure: Net loss ₹3.6 Cr

Open full results → Read the filing ↗

18 May 2026 17:00 IST BSE

Financial Results

Bharat Parenterals Q4 FY26 Results: Net Loss of ₹8.2 Cr, Loss Narrows

Bharat Parenterals Ltd reported revenue from operations of ₹99.6 Cr (-4.2% YoY) and a net loss of ₹8.2 Cr for Q4 FY26.

Key figure: Net loss ₹8.2 Cr

Open full results → Read the filing ↗

18 May 2026 17:00 IST BSE

Financial Results

Bharat Parenterals Financial Results

Bharat Parenterals reported FY26 consolidated revenue of ₹345.4 Crore and recommended a ₹0.07 Crore dividend. The board also re-appointed cost and internal auditors.

Value: ₹0.07 Cr

Read the filing ↗

8 Apr 2026 20:37 IST BSE

Financial Results

Bharat Parenterals Q3 FY26 Results: Net Loss of ₹9.7 Cr, Loss Widens

Bharat Parenterals Ltd reported a net loss of ₹9.7 Cr for Q3 FY26.

Key figure: Net loss ₹9.7 Cr

Open full results → Read the filing ↗